Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Lung Cancer

Free Subscription Articles published in Int J Oncol Retrieve available abstracts of 29 articles: HTML format

Single Articles

September 2026
1. ZHU J, Chen M, Chen N, Ma A, et al
   [Retracted] Glycyrrhetinic acid induces G1?phase cell cycle arrest in human non?small cell lung cancer cells through endoplasmic reticulum stress pathway.
   Int J Oncol. 2026;69:97.
   PubMed     Abstract available
   
   
   
2. XU Y, Duan H, Lu P, Liu F, et al
   The neural stem cell?NSCLC axis: Molecular drivers, microenvironment crosstalk and emerging therapies (Review).
   Int J Oncol. 2026;69:102.
   PubMed     Abstract available
   
   
   August 2026
3. CHUANG TH, Guo JH, Yang JX, Tseng JC, et al
   PDLIM2 acts as a central regulator of ubiquitination, immune signaling, and mitochondrial metabolism in lung cancer suppression (Review).
   Int J Oncol. 2026;69:96.
   PubMed     Abstract available
   
   
   April 2026
4. WEI Q, Huang C, Zhang Y, Zeng H, et al
   IL?6: A key player in the EGFR?TKI?resistant tumor microenvironment and its therapeutic implications (Review).
   Int J Oncol. 2026;68:47.
   PubMed     Abstract available
   
   
   February 2026
5. PANG X, Liu H, Long Y, Wang H, et al
   mTOR in radiotherapy of lung cancer: Mechanisms of radiation resistance and therapeutic implications (Review).
   Int J Oncol. 2026;68:21.
   PubMed     Abstract available
   
   
   
6. GAO J, Mcconnell MJ, Yu B, Li J, et al
   [Expression of Concern] MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion.
   Int J Oncol. 2026;68:16.
   PubMed     Abstract available
   
   
   January 2026
7. LIU L, Yang L, Li H, Shang T, et al
   The tumor microenvironment in lung cancer: Heterogeneity, therapeutic resistance and emerging treatment strategies (Review).
   Int J Oncol. 2026;68:11.
   PubMed     Abstract available
   
   
   December 2025
8. LI X, Wang J, Ge W, Chen X, et al
   Exosomal microRNAs: A new role in the diagnosis and treatment of lung cancer metastases (Review).
   Int J Oncol. 2025;67:101.
   PubMed     Abstract available
   
   
   October 2025
9. WANG F, Hu S, Bian J, Gao Q, et al
   Notch3 mediated TGF?beta1 activation enhances epithelial?mesenchymal transition and cancer stemness in non?small lung cancer.
   Int J Oncol. 2025;67:85.
   PubMed     Abstract available
   
   
   August 2025
10. LI Z, Zhang H, Chen Z, Wu G, et al
    MicroRNA?21: A potential therapeutic target in lung cancer (Review).
    Int J Oncol. 2025;67:67.
    PubMed     Abstract available
    
    
    June 2025
11. WANG SQ, Zhao BX, Liu Y, Wang YT, et al
    [Corrigendum] New application of an old drug: Antitumor activity and mechanisms of doxycycline in small cell lung cancer.
    Int J Oncol. 2025;66:48.
    PubMed     Abstract available
    
    
    
12. SHEN W, Pang H, Xin B, Duan L, et al
    [Corrigendum] Biological effects of BMP7 on small?cell lung cancer cells and its bone metastasis.
    Int J Oncol. 2025;66:51.
    PubMed     Abstract available
    
    
    May 2025
13. YAN H, He Q, Gao Y, He X, et al
    SLC4A7 suppresses lung adenocarcinoma oncogenesis by reducing lactate transport and protein lactylation.
    Int J Oncol. 2025;66:33.
    PubMed     Abstract available
    
    
    April 2025
14. ZHENG Y, Wang K, Mao W, Zhang G, et al
    Abnormal expression of CDC25C in NSCLC is influenced by transcriptional and RNA N6?methyladenosine?mediated post?transcriptional regulation.
    Int J Oncol. 2025;66:27.
    PubMed     Abstract available
    
    
    
15. KAEWPIBOON C, Surapinit S, Malilas W, Moon E, et al
    [Retracted] Feroniellin A?induced autophagy causes apoptosis in multidrug?resistant human A549 lung cancer cells.
    Int J Oncol. 2025;66:30.
    PubMed     Abstract available
    
    
    March 2025
16. XI Y, Zeng S, Tan X, Deng X, et al
    Curcumin inhibits the activity of ubiquitin ligase Smurf2 to promote NLRP3?dependent pyroptosis in non?small cell lung cancer cells.
    Int J Oncol. 2025;66:21.
    PubMed     Abstract available
    
    
    
17. ANDREIKOS D, Spandidos DA, Georgakopoulou VE
    Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review).
    Int J Oncol. 2025;66:23.
    PubMed     Abstract available
    
    
    January 2025
18. KIM H, Jung SH, Jo S, Han JW, et al
    Anti?angiogenic effect of Bryopsis plumosa?derived peptide via aquaporin 3 in non?small cell lung cancer.
    Int J Oncol. 2025;66:5.
    PubMed     Abstract available
    
    
    
19. WANG Y, Fleishman JS, Li Y, Cao Y, et al
    Non?coding RNA?mediated epigenetic modification of ferroptosis in non?small cell lung cancer (Review).
    Int J Oncol. 2025;66:8.
    PubMed     Abstract available
    
    
    November 2024
20. SUN Y, Lian Y, Mei X, Xia J, et al
    Cinobufagin inhibits M2?like tumor?associated macrophage polarization to attenuate the invasion and migration of lung cancer cells.
    Int J Oncol. 2024;65:102.
    PubMed     Abstract available
    
    
    August 2024
21. ZHANG W, Liu K, Pei Y, Ma J, et al
    [Retracted] Mst1 regulates non?small cell lung cancer A549 cell apoptosis by inducing mitochondrial damage via ROCK1/F?actin pathways.
    Int J Oncol. 2024;65:75.
    PubMed     Abstract available
    
    
    
22. WU S, Zhao Q, Liu S, Kuang J, et al
    Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non?small cell lung cancer.
    Int J Oncol. 2024;65:77.
    PubMed     Abstract available
    
    
    July 2024
23. TAYLOR J, Dubois F, Bergot E, Levallet G, et al
    Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review).
    Int J Oncol. 2024;65:68.
    PubMed     Abstract available
    
    
    June 2024
24. TAI F, Zhai R, Ding K, Zhang Y, et al
    Long non?coding RNA lung cancer?associated transcript 1 regulates ferroptosis via microRNA?34a?5p?mediated GTP cyclohydrolase 1 downregulation in lung cancer cells.
    Int J Oncol. 2024;64:64.
    PubMed     Abstract available
    
    
    April 2024
25. XIE L, Xie D, Du Z, Xue S, et al
    A novel therapeutic outlook: Classification, applications and challenges of inhalable micron/nanoparticle drug delivery systems in lung cancer (Review).
    Int J Oncol. 2024;64:38.
    PubMed     Abstract available
    
    
    March 2024
26. LI S, Li Z, Huang L, Geng Z, et al
    SLCO4A1, as a novel prognostic biomarker of non?small cell lung cancer, promotes cell proliferation and migration.
    Int J Oncol. 2024;64:30.
    PubMed     Abstract available
    
    
    
27. WU G, Wang D, Xiong F, Wang Q, et al
    The emerging roles of CEACAM6 in human cancer (Review).
    Int J Oncol. 2024;64:27.
    PubMed     Abstract available
    
    
    December 2023
28. SHIE WY, Chu PH, Kuo MY, Chen HW, et al
    Acidosis promotes the metastatic colonization of lung cancer via remodeling of the extracellular matrix and vasculogenic mimicry.
    Int J Oncol. 2023;63:136.
    PubMed     Abstract available
    
    
    November 2023
29. HU X, Ren J, Xue Q, Luan R, et al
    Anti?PD?1/PD?L1 and anti?CTLA?4 associated checkpoint inhibitor pneumonitis in non?small cell lung cancer: Occurrence, pathogenesis and risk factors (Review).
    Int J Oncol. 2023;63:122.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum